Chromadex Corp Stock
Chromadex Corp Stock
A very strong showing by Chromadex Corp today, with an increase of €0.10 (3.160%) compared to yesterday's price.
We see a rather positive sentiment for Chromadex Corp with 10 Buy predictions and 2 Sell predictions.
With a target price of 5 € there is a hugely positive potential of 55.28% for Chromadex Corp compared to the current price of 3.22 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chromadex Corp | 3.160% | -10.056% | -0.617% | 170.588% | 140.299% | -55.890% | - |
Organovo Holdings Inc. | -1.910% | -14.545% | -2.083% | -47.132% | -8.382% | -88.191% | -94.683% |
Intellia Therapeutics Inc | 0.360% | -4.272% | -23.980% | -43.418% | -33.040% | -72.425% | 27.073% |
VBI Vaccines Inc. | 1.470% | -5.479% | 4.151% | -75.247% | 4.151% | -99.319% | -98.919% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat